An overview on recent patents and technologies on nanoparticles for nucleic acid delivery

References

• Granot Y, Peer D. Delivering the right message: challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics-an innate immune system standpoint. Semin Immunol. 2017 Dec;34:68–77. doi: 10.1016/j.smim.2017.08.015
   PubMed Web of Science ®Google Scholar
• Yadav K, Sahu KK, Sucheta, et al. Biomedical applications of nanomaterials in the advancement of nucleic acid therapy: mechanistic challenges, delivery strategies, and therapeutic applications. Int J Biol Macromol. 2023 Jun 30;241:124582. doi: 10.1016/j.ijbiomac.2023.124582
   PubMed Web of Science ®Google Scholar
• Talap J, Zhao J, Shen M, et al. Recent advances in therapeutic nucleic acids and their analytical methods. J Pharm Biomed Anal. 2021 Nov 30;206:114368. doi: 10.1016/j.jpba.2021.114368
   PubMed Web of Science ®Google Scholar
• Makinen P, Ruotsalainen AK, Yla-Herttuala S. Nucleic acid-based therapies for atherosclerosis. Curr Atheroscler Rep. 2020 Feb 7;22(2):10. doi: 10.1007/s11883-020-0826-2
   PubMed Web of Science ®Google Scholar
• Ramasamy T, Munusamy S, Ruttala HB, et al. Smart nanocarriers for the delivery of nucleic acid-based therapeutics: a comprehensive review. Biotechnol J. 2021 Feb;16(2):e1900408.
   PubMed Web of Science ®Google Scholar
• McNamara K, Tofail SAM. Nanoparticles in biomedical applications. Adv Phys: X. 2017 Jan 2;2(1):54–88.
   Web of Science ®Google Scholar
• Mabrouk M, Das DB, Salem ZA, et al. Nanomaterials for biomedical applications: production, characterisations, recent trends and difficulties. Molecules. 2021 Feb 18;26(4):1077. doi: 10.3390/molecules26041077
   PubMed Web of Science ®Google Scholar
• Paliwal R, Paliwal SR, Kenwat R, et al. Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opin Ther Pat. 2020 Mar;30(3):179–194. doi: 10.1080/13543776.2020.1720649
   PubMed Web of Science ®Google Scholar
• Schlake T, Thess A, Fotin-Mleczek M, et al. Developing mRNA-vaccine technologies. RNA Biol. 2012 Nov;9(11):1319–1330.
   PubMed Web of Science ®Google Scholar
• Mendes BB, Conniot J, Avital A, et al. Nanodelivery of nucleic acids. Nat Rev Meth Primers. 2022 Apr 14;2(1):24. doi: 10.1038/s43586-022-00104-y
   PubMedGoogle Scholar
• Yoo YJ, Lee CH, Park SH, et al. Nanoparticle-based delivery strategies of multifaceted immunomodulatory RNA for cancer immunotherapy. J Control Release. 2022 Mar;343:564–583. doi: 10.1016/j.jconrel.2022.01.047
   PubMed Web of Science ®Google Scholar
• Duchene D, Gref R. Small is beautiful: surprising nanoparticles. Int J Pharm. 2016 Apr 11;502(1–2):219–231. doi: 10.1016/j.ijpharm.2016.02.016
   PubMedGoogle Scholar
• Ramazanli V. Effect of ph and temperature on the synthesis of silver nano particles extracted from olive leaf. Adv Biol Earth Sci. 2021;6(2):169–173.
   Google Scholar
• Ahmadov I, Bandaliyeva A, Nasibova A, et al. The synthesis of the silver nanodrugs in the medicinal plant baikal skullcap (Scutellaria baicalensis Georgi) and their antioxidant, antibacterial activity. Adv Biol Earth Sci. 2020;5(2):103–118.
   Google Scholar
• Eftekhari A, Kryschi C, Pamies D, et al. Natural and synthetic nanovectors for cancer therapy. Nanotheranostics. 2023;7(3):236–257. doi: 10.7150/ntno.77564
   PubMedGoogle Scholar
• Baran A, Fırat Baran M, Keskin C, et al. Investigation of antimicrobial and cytotoxic properties and specification of silver nanoparticles (AgNps) derived from Cicer arietinum L. Green leaf extract [Original Research]. Front Bioeng Biotechnol. 2022;10:10. doi: 10.3389/fbioe.2022.855136
   Web of Science ®Google Scholar
• Han X, Xu K, Taratula O, et al. Applications of nanoparticles in biomedical imaging. Nanoscale. 2019 Jan 17;11(3):799–819. doi: 10.1039/C8NR07769J
   PubMed Web of Science ®Google Scholar
• Hou X, Zaks T, Langer R, et al. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078–1094. doi: 10.1038/s41578-021-00358-0
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao X, Cheng Y, et al. Iron oxide nanoparticles-based vaccine delivery for cancer treatment. Mol Pharm. 2018 May 7;15(5):1791–1799. doi: 10.1021/acs.molpharmaceut.7b01103
   PubMedGoogle Scholar
• Basberg B. Patents and the measurement of technological change: a survey of the literature. Res Policy. 1987;16(2–4):131–141. doi: 10.1016/0048-7333(87)90027-8
   Web of Science ®Google Scholar
• Ernst H. Patent information for strategic technology management. World Patent Inf. 2003 Sep 01;25(3):233–242.
   Google Scholar
• SdA P, Quoniam L. Intellectual property and patent prospecting as a basis for knowledge and innovation – a study on mobile information technologies and virtual processes of communication and management. RAI Revista de Administração e Inovação. 2017;14(4):301–310. doi: 10.1016/j.rai.2017.07.006
   Google Scholar
• WIPO. World intellectual property indicators 2022. Geneva: World Intellectual Property Organization; 2022. doi: 10.34667/tind.47082
   Google Scholar
• Machado BAS, Hodel KVS, Fonseca L, et al. The Importance of vaccination in the context of the COVID-19 PAndemic: A Brief Update Regarding The Use Of Vaccines. Vaccines. 2022 Apr 12;10(4):591. doi: 10.3390/vaccines10040591
   PubMed Web of Science ®Google Scholar
• Machado BAS, Hodel KVS, Fonseca L, et al. The importance of RNA-based vaccines in the fight against COVID-19: an overview. Vaccines (Basel). 2021 Nov 17;9(11):1345. doi: 10.3390/vaccines9111345
   PubMed Web of Science ®Google Scholar
• El-Hammadi MM, Arias JL. An update on liposomes in drug delivery: a patent review (2014-2018). Expert Opin Ther Patents. 2019 Nov 02;29(11):891–907.
   PubMed Web of Science ®Google Scholar
• Grijalvo S, Aviñó A, Eritja R. Oligonucleotide delivery: a patent review (2010 – 2013). Expert Opin Ther Patents. 2014 Jul 01;24(7):801–819.
   PubMed Web of Science ®Google Scholar
• Zhang H-L. Current status and patent prospective of lipid nanoparticle for mRNA delivery. Expert Opin Ther Patents. 2023 Feb 01;33(2):125–131. doi: 10.1080/13543776.2023.2195541
   PubMed Web of Science ®Google Scholar
• Chan WCW. Nano research for COVID-19. ACS Nano. 2020 Apr 28;14(4):3719–3720.
   PubMed Web of Science ®Google Scholar
• Ahmadian E, Janas D, Eftekhari A, et al. Application of carbon nanotubes in sensing/monitoring of pancreas and liver cancer. Chemosphere. 2022 Sep;302:134826. doi: 10.1016/j.chemosphere.2022.134826
   PubMed Web of Science ®Google Scholar
• Clarivate. DWPI country/region coverage. 2023.
   Google Scholar
• Office EP. Patent families. 2023.
   Google Scholar
• Pranckutė R. Web of science (WoS) and Scopus: the titans of bibliographic information in today’s academic world. 2021;9(1):12. doi: 10.3390/publications9010012
   Google Scholar
• Wang H, Zhou Y, Sun Q, et al. Update on nanoparticle-based drug delivery system for anti-inflammatory treatment [review]. Front Bioeng Biotechnol. 2021 Feb 17;9:9. doi: 10.3389/fbioe.2021.630352
   Web of Science ®Google Scholar
• WIPO. Patents. 2023.
   Google Scholar
• Abedini-Nassab R, Mahdaviyan N. Recent patents and advances on nanotechnologies against coronavirus. Recent Pat Nanotechnol. 2021;15(4):322–330. doi: 10.2174/1872210514666201110125536
   PubMed Web of Science ®Google Scholar
• Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus pandemic (COVID-19) 2020;Our World In Data.
   Google Scholar
• Arroyabe MF. The role of patent expiration in acquisition decision and target selection in the pharmaceutical industry. R&D Management. 2021;51(5):521–537. doi: 10.1111/radm.12462
   Web of Science ®Google Scholar
• Ahmad U. Patented nanopharmaceuticals: a hope for patent expired formulations. Intel Prop Rights. 2014 Feb 11;2(2). doi: 10.4172/2375-4516.1000e104
   Google Scholar
• Llamas T. Protecting inventions by patent in multiple countries - ABG IP 2023;ABG IP.
   Google Scholar
• WIPO. Inside WIPO. 2023.
   Google Scholar
• Office EP. The EPO at a glance. 2023.
   Google Scholar
• Grimaldi M, Greco M, Cricelli L. A framework of intellectual property protection strategies and open innovation. J Bus Res. 2021 Feb 01;123:156–164. doi: 10.1016/j.jbusres.2020.09.043
   Web of Science ®Google Scholar
• WIPO. PCT – the international patent system. 2023.
   Google Scholar
• Liu N, Guan J. Policy and innovation: nanoenergy technology in the USA and China. Energy Policy. 2016 Apr 1;91:220–232. doi: 10.1016/j.enpol.2016.01.020
   Web of Science ®Google Scholar
• Wu L, Zhu H, Chen H, et al. Comparing nanotechnology landscapes in the US and China: a patent analysis perspective. J Nanopart Res. 2019 Aug 13;21(8):180. doi: 10.1007/s11051-019-4608-0
   Web of Science ®Google Scholar
• Dong H, Gao Y, Sinko PJ, et al. The nanotechnology race between China and the United States. Nano Today. 2016;11(1):7–12. doi: 10.1016/j.nantod.2016.02.001
   Web of Science ®Google Scholar
• Farjadian F, Ghasemi A, Gohari O, et al. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine (Lond). 2019 Jan;14(1):93–126.
   PubMed Web of Science ®Google Scholar
• Pokrajac L, Abbas A, Chrzanowski W, et al. Nanotechnology for a sustainable future: addressing global challenges with the international Network4Sustainable nanotechnology. ACS Nano. 2021;15(12):18608–18623. doi: 10.1021/acsnano.1c10919
   PubMed Web of Science ®Google Scholar
• Kanno AI, Barbosa MMF, Moraes L, et al. SARS-CoV-2 vaccine development and how Brazil is contributing. Genet Mol Biol. 2021;44(1 Suppl 1):e20200320. doi: 10.1590/1678-4685-gmb-2020-0320
   PubMed Web of Science ®Google Scholar
• Tavares JL, Cavalcanti IDL, Santos Magalhaes NS, et al. Nanotechnology and COVID-19: quo vadis? J Nanopart Res. 2022;24(3):62. doi: 10.1007/s11051-022-05452-0
   PubMed Web of Science ®Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018 Sep 19;16(1):71. doi: 10.1186/s12951-018-0392-8
   PubMedGoogle Scholar
• Rambaran T, Schirhagl R. Nanotechnology from lab to industry – a look at current trends. Nanoscale Adv. 2022 Sep 13;4(18):3664–3675. doi: 10.1039/D2NA00439A
   PubMed Web of Science ®Google Scholar
• OECD AA. Opportunities and risks of nanotechnologies report in co-operation with the OECD international futures programme. 2016.
   Google Scholar
• Gao Y, Jin B, Shen W, et al. China and the United States–Global partners, competitors and collaborators in nanotechnology development. Nanomedicine. 2016 Jan;12(1):13–19.
   PubMed Web of Science ®Google Scholar
• Research B. Nanoparticles market: biotechnology, drug delivery & development. 2023.
   Google Scholar
• Resende Rodrigo R, Fernanda Maria Policarpo T, Luiz Orlando L, et al., inventors; Universidade Federal de Minas Gerais, assignee. Complexed carbon nanoparticles used for delivering nucleic acids, such as genes or small interfering ribonucleic acid to cells including cells of difficult transfection, are functionalized with polyethyleneimine. BR patent BR10201617712A. 2018 Feb 14.
   Google Scholar
• Siri JGS, Fernando CAN, De Silva SNT. Nanotechnology and protection of intellectual property: emerging trends. Recent Pat Nanotechnol. 2020;14(4):307–327. doi: 10.2174/1872210514666200612174317
   PubMed Web of Science ®Google Scholar
• Moderna. Pioneering mRNA technology. 2023.
   Google Scholar
• Dunleavy K. The top 20 pharma companies by 2021 revenue. 2022.
   Google Scholar
• Gaviria M, Kilic B. mRNA-1273 vaccine patent landscape (for NIH-moderna vaccine) - public citizen. 2020.
   Google Scholar
• Giuseppe C, Sunny H, Yi-Chun Huang E, et al. inventors; ModernaTx Inc. assignee. Tropical disease vaccines. US patent WO2017070624A1. 2017 Apr 27.
   Google Scholar
• Ciaramella G, Inventor; ModernaTx Inc. assignee. High potency immunogenic compositions. US patent WO2018151816. 2018 Aug 23.
   Google Scholar
• Ciaramella G, Inventor; ModernaTX, Inc, assignee. Ebola/Marburg vaccines. US patent WO2017015457A1. 2017 Jan 26.
   Google Scholar
• Neumann PJ, Cohen JT, Kim DD, et al. Consideration of value-based pricing for treatments and vaccines is important, even in the COVID-19 pandemic. Health Aff. 2021 Jan;40(1):53–61.
   Web of Science ®Google Scholar
• Storz U. The patent maze of COVID-19 vaccines. Expert Opin Ther Pat. 2021 Dec;31(12):1177–1188. doi: 10.1080/13543776.2021.1945581
   PubMed Web of Science ®Google Scholar
• Shen AK, Hughes Iv R, DeWald E, et al. Ensuring equitable access to COVID-19 vaccines in the US: current system challenges and opportunities. Health Aff. 2021 Jan;40(1):62–69.
   Web of Science ®Google Scholar
• Moderna loses key patent challenge. Nat Biotechnol. 2020 Sep;38(9):1009. doi: 10.1038/s41587-020-0674-1
   PubMed Web of Science ®Google Scholar
• Ben Hirschler PS. Japan’s Takeda clinches $62 billion Shire deal as pharma M&A rolls on. US. 2018.
   Google Scholar
• Chen D, Love KT, Chen Y, et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J Am Chem Soc. 2012;134(16):6948–6951. doi: 10.1021/ja301621z
   PubMed Web of Science ®Google Scholar
• Lubke T, Lobel P, Sleat DE. Proteomics of the lysosome. Biochim Biophys Acta. 2009 Apr;1793(4):625–635. doi: 10.1016/j.bbamcr.2008.09.018
   PubMed Web of Science ®Google Scholar
• Derosa F, Charles GB, Heartlein M, Inventors; shire human genetic therapies, inc. assignee. lipid-derived neutral nanoparticles. US patent WO/2013/149141. 2013 Oct 3.
   Google Scholar
• Le-le L, Cai-Zhang X, Jian Z, Inventors; Chinese academy of science, assignee. New cation-coated metal-nucleic acid nanoprobe useful in preparation of cells of internal RNA sensing device, comprises drug molecule, nucleic acid probe and metal ion formed by coordination. China patent CN113322255B. 2022.
   Google Scholar
• Tian H-Y, Hu Ying-Ying G-P, Lin L, et al., inventors; Chinese academy of sciences, assignee. New cationic polymer (I) as vaccine carrier in preparation of nano-vaccine, where nano-vaccine comprises cationic polymer, antigen and adjuvant. CN patent CN114591502A. 2022 Jun 7.
   Google Scholar
• Tan W-H, Peng-Hui Z, Yan L, et al., inventors; PLA academy of military sciences, assignee. New bivalent ionizable lipid compound i.E aryl compound of formula (I) or salts, stereoisomers, tautomers, solvates, chelates, non-covalent complexes and/or prodrugs useful in preparing e.g. nucleic acid medicine, vaccine, small molecule medicine, polypeptide. CN patent CN114213346B. 2022 May 20.
   Google Scholar
• Scandura A. The role of scientific and market knowledge in the inventive process: evidence from a survey of industrial inventors. J Technol Transf. 2019 Aug 1;44(4):1029–1069.
   Web of Science ®Google Scholar
• Mendonca MCP, Kont A, Kowalski PS, et al. Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids. Drug Discov Today. 2023 Mar;28(3):103505.
   PubMed Web of Science ®Google Scholar
• Let’s talk about lipid nanoparticles. Nat Rev Mater. 2021 Feb 1;6(2):99–99. doi:10.1038/s41578-021-00281-4
   Web of Science ®Google Scholar
• Huang T, Peng L, Han Y, et al. Lipid nanoparticle-based mRNA vaccines in cancers: current advances and future prospects. Front Immunol. 2022;13:922301. doi: 10.3389/fimmu.2022.922301
   PubMed Web of Science ®Google Scholar
• Amit K, Steven R, Malcolm D, et al., inventors; HDT Bio Corp. assignee. Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for viral RNA polymerase region and protein antigen. US patent US11458209B2. 2022 Oct 4.
   Google Scholar
• Danilo CASIMIRO, Sudha CHIVUKULA, Frank DEROSA, et al., inventors; SANOFI SA, assignee. Lipid nanoparticles for delivering mRNA vaccines. US patent WO2022099003A1. 2022 May 12.
   Google Scholar
• Jun GAO, Eric HSU, Anthony C, inventors; ENGENE INC, assignee. Chitosan-derivative nanoparticle useful in composition for delivering nucleic acid molecule to cell, and in therapeutic compositions for treating e.g. heart attack, comprises chitosan functionalized with arginine and hydrophilic polyol. US patent US20220133907A1. 2022 May 5.
   Google Scholar
• Vered R, Naiomi M, Moshe F-B, et al., inventors; TEVA PHARMA, assignee. Composition, useful for treating e.g. autoimmune disease and multiple sclerosis, comprises a nanoparticle, any one of a peptide, a polysaccharide or a glycoprotein and a carrier. US patent NZ546379A. 2010 Apr 30.
   Google Scholar
• Mirkin Chad A, Giljohann David A, Seferos Dwight S, et al., inventors; assignee. Nanoparticle composition e.g. gold nanoparticle useful for regulating expression of target polynucleotide e.g. RNase H, RNase D, RNase L, Dicer and Argonaute, comprises a RNA polynucleotide in association with nanoparticle. US patent US15809464A. Northwestern University. 2019 Aug 27.
   Google Scholar
• Anja T, Anne-Kristin T, Bus Tanja E, et al., inventors; UNIV JENA FRIEDRICH SCHILLERDE, assignee. Nanostructured carrier system useful for delivering RNA interference, comprises carrier shell comprising hydrophobic shell polymers, complexing polymers and hydrophilic agents. US patent US11376336B2. 2022 Jul 5.
   Google Scholar
• Fink J. Dispersions, emulsions, and foams. 2021:907–940.
   Google Scholar
• Xiao-Ling GAO, Jia-Lin HUANG, Gan JIANG, et al. inventors; Shanghai Jiao Tong University, assignee. Lipoprotein nano-delivery system useful for preparing medicine for preventing or treating tumor or central nervous system disease, comprises lipid, apolipoprotein and solid phase core. CN patent CN108451929B. 2021 Apr 16.
   Google Scholar
• Suvaci E, Ozel E. Hydrothermal Synthesis. 2020.
   Google Scholar
• Ina K, Jörg P, Claudia W, et al. inventors; Henkel Kgaa, assignee. Composite material, useful e.g. The coating of implants, treatment of hairs and as additive for food, comprises a calcium salt, a polymer component and a luminescence-giving doping component comprising a metal ion and/or -salt. WO patent WO2009024372A9. 2009 Aug 27.
   Google Scholar
• Roh YH, Lee YS, Kim YM, inventors;, Assignee. Nanocomposite pour l’administration de médicament à base d’acide nucléique à l’aide d’un nanocristal de cellulose hautement dispersible. Korea Yonsei University 2022.
   Google Scholar
• Nam NH, Luong NH. Chapter 7 - nanoparticles: synthesis and applications. In: Grumezescu V, and Grumezescu A, editors. Materials for biomedical engineering. Netherlands: Elsevier; 2019. p. 211–240. doi: 10.1016/B978-0-08-102814-8.00008-1
   Google Scholar
• Filho Luiz Ricardo O, Goularts Isabela Maria B, Riello Fabiane N, et al., inventors; Univ Federal Uberlandia, assignee. Modifying surface of electrodes for the construction of electrochemical biosensors, involves applying rhodamine spread throughout the area on the surface of the working electrode, and performing physical adsorption. BR patent US20220170921A1. 2022 Jun 2.
   Google Scholar
• Li Y, Chen S, Liu N, et al. A systematic investigation of key factors of nucleic acid precipitation toward optimized DNA/RNA isolation. Biotechniques. 2020 Apr;68(4):191–199.
   PubMed Web of Science ®Google Scholar
• Ford William S, Wessels Jurina F, Harnack Oliver S, et al., inventors; Sony Group Corp, assignee. Production of platinum particle nucleic acid composite comprising subnanometer size particles. DE Patent US8227582B2. 2012 Jul 24.
   Google Scholar
• Da-Xiang C, Bi-Feng P, Feng G, et al., inventors; Shanghai Jiao Tong University, assignee. Preparation method and use method of polylactic acid tree-like molecule-modified magnetic nano particles. CN patent CN101310850B. 2011 Mar 23.
   Google Scholar
• Robert D, inventor; Kansas State University, assignee. RNA stabilizing nanoparticles. US patent WO2022178543A1. 2022.
   Google Scholar
• Huan M, inventor; Chinese academy of science, assignee. Nucleic acid delivery nano-carrier acting on cells with phagocytic ability as well as preparation method and application of nucleic acid delivery nano-carrier. CN patent CN114376988A. 2022 Apr 22.
   Google Scholar
• Patra JK, Fraceto LF, Das G, et al. Green nanoparticles synthesis and biomedical applications. Synthesis And Biomedical Applications. 2020.
   Google Scholar
• Abbasi BA, Iqbal J, Nasir JA, et al. Environmentally friendly green approach for the fabrication of silver oxide nanoparticles: characterization and diverse biomedical applications. Microsc Res Tech. 2020 Nov;83(11):1308–1320.
   PubMed Web of Science ®Google Scholar
• Elkomy MH, Ali AA, Eid HM. Chitosan on the surface of nanoparticles for enhanced drug delivery: a comprehensive review. J Control Release. 2022 Nov;351:923–940. doi: 10.1016/j.jconrel.2022.10.005
   PubMed Web of Science ®Google Scholar
• Rani M, Keshu SU. Chapter 3 - Green nanomaterials: An overview. In: Shanker U, Hussain C, and Rani M, editors Green Functionalized nanomaterials for environmental applications. Netherlands: Elsevier; 2022. p. 43–80. doi: 10.1016/B978-0-
   Google Scholar
• Joshua F, Sushma G, Ankita M, et al. inventors; ModernaTX Inc. assignee. Treating cancer in human patient such as hematological cancer, involves administering first mRNA encoding human OX40L and second mRNA encoding immune potentiator which is cell-associated cytokine that activates T-cells and neurokinin cells. US patent IN202117016800A. 2022 Jan 7.
   Google Scholar
• Dave H, Yasufumi K, inventors; Wayne Cancer Inst John, assignee. DNA cancer vaccine and methods for its use. US patent AU770227B2. 2004 Feb 19.
   Google Scholar
• Xiao CHEN, Ying W, inventors; Shanghai Linglan Biotechnology Co. Ltd. assignee. Silica nano material delivery system for capturing and treating circulating tumor cells. CN patent CN108186603A. 2018 Jun 22.
   Google Scholar
• Thomas Willian R, Khalid G, Lomas Manuel M, et al., inventors; MIDATECH LTDGB, assignee. Nanoparticle useful for preparation of medicament for treatment of cancer, viral infection or macular degeneration, comprises core including metal and/or semiconductor atoms, covalently linked to several ligands comprising RNA ligand. US patent ES2655069T3. 2018 Feb 16.
   Google Scholar
• Simberg Dmitri SD, L Y-T, inventors; University of California, assignee. Layered particles for retrieving DNA released from cells from a gastrointestinal tract sample and methods for making and using them. US patent US9730637B2. 2017 Aug 15.
   Google Scholar
• Norouzi S, Soltani S, Alipour E. Recent advancements in biosensor designs toward the detection of intestine cancer miRNA biomarkers. Int j biol macromol. 2023 Aug 1;245:125509. doi: 10.1016/j.ijbiomac.2023.125509
   PubMed Web of Science ®Google Scholar
• Lu ZG, Shen J, Yang J, et al. Nucleic acid drug vectors for diagnosis and treatment of brain diseases. Signal Transduct Target Ther. 2023 Jan 17;8(1):39. doi: 10.1038/s41392-022-01298-z
   PubMed Web of Science ®Google Scholar
• Takashi N, Hideyoshi H, Yusuke S, et al., inventors; Univ hokkaido nat univ corpjp, assignee. Lipid Nanoparticle. JP patent WO2022176953A1. 2022 Aug 25.
   Google Scholar
• Shrirang K, Derosa Frank LS, inventors; Translate Bio Inc. assignee. Rectal delivery of messenger RNA. US patent AU2020408059A1. 2022 Aug 11.
   Google Scholar
• Kramarczyk JFS, Hassett Kimberly C, John Shinu C, et al., inventors; ModernaTX Inc. assignee. Human cytomegalovirus vaccine. US patent US11406703B2. 2022 Aug 9.
   Google Scholar
• STEPHAN M, N U, inventors; Tidal Therapeutics Inc. assignee. Nanoparticle to treat cancer, has targeting ligand binding to professional phagocyte and nucleic acid encoding protein with first and second binding domains specific to cell surface protein expressed by immune and cancer cells, respectively. US patent CN115135764A. 2022 Sep 30.
   Google Scholar
• Haifa S inventor; Methodist Hospital, assignee. Composition used in prophylaxis or amelioration of human metastatic cancer, comprises a therapeutic cancer vaccine having mRNA molecules comprised within polyplex or protein core particles comprising positively-charged polymer or protein. US patent US20220305103A1. 2022 Sep 29.
   Google Scholar
• Translate Bio Inc. assignee. Lipid nanoparticle used to e.g. deliver mRNA, and treat cystic fibrosis and ocular disease, comprises cationic lipid, polyethylene glycol-modified lipid and helper lipid i.E. 1, 2-dierucoyl-sn-glycero-3-phosphoethanolamine encapsulating mRNA patent JP2022541740A. 2022 Sep 27.
   Google Scholar
• Shrirang K, Ashish S, Vargas MN, et al., inventors; Translate Bio Inc. assignee. Stable Liquid Lipid Nanoparticle Formulations. US patent US20220287966A1. 2022 Sep 15.
   Google Scholar
• Joshua R, Sean E, Matthew B, et al.Inventors; Poseida Therapeutics Inc. assignee. Compositions et procédés d’administration d’acides nucléiques. US patent WO2022182792A1. 2022 Sep 1.
   Google Scholar
• Meredith P, Dipendra G, Serenus H, et al., Inventors; ModernaTX Inc. assignee. Lipid nanoparticle compositions and methods of formulating the same. US patent US20220273693A1. 2022.
   Google Scholar
• James MC, inventor; NUTCRACKER THERAPEUTICS INC. assignee. Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery. US patent US11446394B2. 2022 Sep 20.
   Google Scholar
• Chun KS, inventor; Kim Sung Chun, assignee. Polyelectrolyte multilayer nanoparticles PEMN containing active ingredients their use and their preparation. KR patent KR2022124057A. 2022 Sep 13.
   Google Scholar
• Sankaran T, Kingshuk D, inv, assignee. Lipid-polymer based complexation and delivery of nucleic acids. US patent US11434317B2. 2022.
   Google Scholar
• Lu L, Xue-Ming T, Sai-Sai W, et al., inventors; Guiyi tech shanghai CO LTD, assignee. Preparation method of nucleic acid nanoparticles. CN patent CN115040493A. 2022 Sep 13.
   Google Scholar
• Yang Mo YOO, Jung Joon KIM, Bong-Gun JU, et al., Inventors; edge care Co. Ltd. assignee. Drug delivery system and operation method thereof. KR patent KR2432810B1. 2022 Aug 16.
   Google Scholar
• MC A, Joseph SA, Inventors; univ northwestern, assignee. acides nucléiques sphériques de nanoparticules lipidiques. US patent WO2022155149A1. 2022 Jul 21.
   Google Scholar
• Sajeev KOHLI, Zehtab YA, Pu C, Inventors; nanopeptide Qingdao biomedicine Co. Ltd. assignee. Method for constructing nanoparticle-based drug carriers by protein crown modulation. CN patent CN114787628A. 2022.
   Google Scholar
• Shui-Xiang Y, Inventor; Suzhou xianglong biomedical technology Co. Ltd. assignee. Tumor vaccine based on mRNA (messenger ribonucleic acid) as well as preparation and combined. CN patent CN114588255A. 2022.
   Google Scholar
• SM H, Jason A, Sherpard SB, et al., Inventors; modernatx inc. assignee. Methods of preparing lipid nanoparticles. US patent TW202220637A. 2022.
   Google Scholar
• Chen Y, Xiong S-H, Li F, et al. Delivery of therapeutic small interfering RNA: the current patent-based landscape. Mol Ther Nucleic Acids. 2022 Sep 13;29:150–161. doi: 10.1016/j.omtn.2022.06.011
   PubMedGoogle Scholar